Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 121.8 M124.8 M106.8 M103 M100.5 M102.1 M 412.4 M Research & development —————— — Operating income -520.1 M-330.3 M-8.6 M-13.6 M-3.4 M14.8 M -10.8 M Non-Operating Income, Total -5.6 M-17.1 M2.5 M1.1 M10.2 M4.6 M 18.4 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -5.6 M-19.9 M-2.6 M1.1 M9.7 M4.8 M 13 M Unusual income/expense 02.8 M5.1 M0500 K-200 K 5.4 M Pretax income -548 M-370.7 M-28.7 M-35.6 M-12.3 M-1.2 M -77.8 M Equity in earnings —————— — Taxes 14.9 M4.2 M-12.8 M-3.1 M11.3 M12 M 7.4 M Non-controlling/minority interest —————— — After tax other income/expense -300 K-2 M100 K-2.3 M-400 K-2.1 M -4.7 M Net income before discontinued operations -562.9 M-374.9 M-15.9 M-32.5 M-23.6 M-13.2 M -85.2 M Discontinued operations 0000—— — Net income -562.9 M-374.9 M-15.9 M-32.5 M-23.6 M-13.2 M -85.2 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -562.9 M-374.9 M-15.9 M-32.5 M-23.6 M-13.2 M -85.2 M Basic earnings per share (Basic EPS) -6.25-4.14-0.17-0.25-0.25-0.14 -0.81 Diluted earnings per share (Diluted EPS) -6.25-4.14-0.17-0.25-0.25-0.14 -0.81 Average basic shares outstanding ————93.6 M94.8 M — Diluted shares outstanding ————93.6 M94.8 M — EBITDA -500.6 M-310.7 M11 M5.7 M16.4 M34.4 M 67.5 M EBIT -520.1 M-330.3 M-8.6 M-13.6 M-3.4 M14.8 M -10.8 M Cost of revenue 534.8 M576.8 M578.6 M529.4 M512.9 M539 M 2.16 B Other cost of goods sold 534.8 M576.8 M578.6 M529.4 M512.9 M539 M 2.16 B Depreciation & amortization (cash flow) 19.5 M19.6 M19.6 M19.3 M19.8 M19.6 M 78.3 M